biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs > question for MBT123

<< Previous

Bullboard Posts

Next >>

Comment by JDavenporton May 13, 2021 10:48am

233 Views

Post# 33191310

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:question for MBT123

This is a response to MBT123's post before this post (counting Re:s can be difficult for some people. Others turn on thread view.)

The MBT123 post is sexist, abusive, myopic, ignores the opinion of Chiesi scientists and physicians, XOMA scientists, ignores the science and shows no insight whatsoever into anything, especially how biotechs work, how lab work is affected by Covid-19, how deals get done, etc, etc.

In short, MBT123 may know a lot of stuff but he is certainly not willing to acknowledge publicly that he knows anything.

That was a shameful post.

jd

<< Previous

Bullboard Posts

Next >>

The top 10 Canadian medical stocks